Literature DB >> 10235128

Hepatic lipid peroxidation in hereditary hemochromatosis and alcoholic liver injury.

O Niemelä1, S Parkkila, R S Britton, E Brunt, C Janney, B Bacon.   

Abstract

Studies in experimental animals have indicated that enhanced lipid peroxidation may play a role in the hepatic injury produced by iron overload or by excessive alcohol consumption. The aim of this study was to compare the formation of lipid peroxidation-derived aldehydes in the liver of patients with hereditary hemochromatosis (HH) and alcohol abuse. Liver biopsy specimens from 10 nondrinking patients with HH were evaluated. These patients were classified as having HH based on hepatic iron index or human leukocyte antigen identity with a known proband. All patients were homozygous for the Cys282Tyr mutation. In addition, 8 patients with alcoholic liver disease were examined, 2 of whom also had hemochromatosis. For comparison, 17 patients with liver diseases unrelated to iron overload or alcohol abuse were studied. Liver biopsy specimens were immunostained for protein adducts with malondialdehyde and 4-hydroxynonenal. Both malondialdehyde- and 4-hydroxynonenal-protein adducts were found from liver specimens of patients with HH and alcohol abuse in more abundant amounts than from patients in a control group. In alcoholics the adducts were primarily in zone 3, whereas in hemochromatosis staining had an acinar zone 1 predominance, which followed the localization of iron. The most abundant amounts of protein adducts were noted in patients with alcohol abuse plus iron overload. The data support the concept that both chronic alcohol use and iron overload induce hepatic lipid peroxidation. Through formation of reactive aldehydic products, excessive alcohol consumption and iron overload may have additive hepatotoxic effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10235128     DOI: 10.1016/s0022-2143(99)90022-7

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  14 in total

1.  HFE genetic variability and risk of alcoholic liver disease: A meta-analysis.

Authors:  Yan-Yan Xu; Yu-Han Tang; Xiao-Ping Guo; Jing Wang; Ping Yao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-10-18

Review 2.  Iron toxicity and chelation therapy.

Authors:  Robert S Britton; Katherine L Leicester; Bruce R Bacon
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

3.  Increased p53 mutation load in nontumorous human liver of wilson disease and hemochromatosis: oxyradical overload diseases.

Authors:  S P Hussain; K Raja; P A Amstad; M Sawyer; L J Trudel; G N Wogan; L J Hofseth; P G Shields; T R Billiar; C Trautwein; T Hohler; P R Galle; D H Phillips; R Markin; A J Marrogi; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

4.  Aldehydes potentiate alpha(2)(I) collagen gene activity by JNK in hepatic stellate cells.

Authors:  F A Anania; L Womack; M Jiang; N K Saxena
Journal:  Free Radic Biol Med       Date:  2001-04-15       Impact factor: 7.376

Review 5.  Nitric oxide and redox regulation in the liver: part II. Redox biology in pathologic hepatocytes and implications for intervention.

Authors:  Diana L Diesen; Paul C Kuo
Journal:  J Surg Res       Date:  2009-10-27       Impact factor: 2.192

6.  Invariant Natural Killer T Cells are Reduced in Hereditary Hemochromatosis Patients.

Authors:  M L Maia; C S Pereira; G Melo; I Pinheiro; M A Exley; G Porto; M F Macedo
Journal:  J Clin Immunol       Date:  2014-12-06       Impact factor: 8.317

Review 7.  Mitochondria and Iron: current questions.

Authors:  Bibbin T Paul; David H Manz; Frank M Torti; Suzy V Torti
Journal:  Expert Rev Hematol       Date:  2016-12-12       Impact factor: 2.929

8.  Iron potentiates acetaminophen-induced oxidative stress and mitochondrial dysfunction in cultured mouse hepatocytes.

Authors:  Mi Sun Moon; John P Richie; Harriet C Isom
Journal:  Toxicol Sci       Date:  2010-07-28       Impact factor: 4.849

9.  Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.

Authors:  Shikha S Sundaram; Ann Halbower; Zhaoxing Pan; Kristen Robbins; Kelley E Capocelli; Jelena Klawitter; Colin T Shearn; Ronald J Sokol
Journal:  J Hepatol       Date:  2016-08-05       Impact factor: 25.083

10.  Effects of 4-hydroxynonenal on mitochondrial 3-hydroxy-3-methylglutaryl (HMG-CoA) synthase.

Authors:  Vinood B Patel; Christina H Spencer; Tracey A Young; Mark O Lively; Carol C Cunningham
Journal:  Free Radic Biol Med       Date:  2007-08-16       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.